Implementation of a Kidney Genetic Service Into the Diagnostic Pathway for Patients With Chronic Kidney Disease in Canada

Implementation of a Kidney Genetic Service Into the Diagnostic Pathway for Patients With Chronic Kidney Disease in Canada

Introduction: Genetic kidney disease (GKD) accounts for 10% to 20% of chronic kidney disease (CKD). Genetic testing using gene panel or targeted exome sequencing (ES) can confirm GKD; however, integration into clinical practice has been hampered by small studies, selective populations, and data pred...

Full description

Saved in:
Bibliographic Details
Main Authors: Clara Schott, Monica Arnaldi, Cadence Baker, Jian Wang, Adam D. McIntyre, Samantha Colaiacovo, Sydney Relouw, Gabriela Almada Offerni, Carla Campagnolo, Logan R. Van Nynatten, Ava Pourtousi, Alexa Drago-Catalfo, Victoria Lebedeva, Michael Chiu, Andrea Cowan, Guido Filler, Lakshman Gunaratnam, Andrew A. House, Susan Huang, Hariharan Iyer, Arsh K. Jain, Anthony M. Jevnikar, Khaled Lotfy, Louise Moist, Faisal Rehman, Pavel S. Roshanov, Ajay P. Sharma, Matthew A. Weir, Kendrah Kidd, Anthony J. Bleyer, Robert A. Hegele, Dervla M. Connaughton
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Kidney International Reports
Subjects:
chronic kidney disease (CKD)
end-stage kidney disease (ESKD)
exome sequencing
gene panels
genetic testing
genomics testing
Online Access:http://www.sciencedirect.com/science/article/pii/S246802492402014X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S246802492402014X

Similar Items